This is a summary of the European public assessment report (EPAR) for Qutenza. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Qutenza.
Therapeutic Indication
### Therapeutic indication Qutenza is indicated for the treatment of peripheral neuropathic pain in adults either alone or in combination with other medicinal products for pain.
Therapeutic Area (MeSH)
ATC Code
N01BX04
ATC Item
capsaicin
Pharmacotherapeutic Group
Anesthetics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| capsaicin | N/A | 辣椒碱 |
EMA Name
Qutenza
Medicine Name
Qutenza
Aliases
N/ANo risk management plan link.
